Karisa C. Schreck, MD

Dr. William H. Sharfman is an associate professor of oncology and dermatology at the Johns Hopkins University School of Medicine. His areas of clinical expertise include cutaneous oncology, dermatology and immunotherapy. He helped create the well-established Melanoma Program at the Johns Hopkins Kimmel Cancer Center in 1994. Dr. Sharfman serves as the director of cutaneous oncology and clinical co-director for oncology at the Johns Hopkins Melanoma Program. He earned his M.D. from the University of Toledo College of Medicine. He completed his residency at Cleveland Clinic and performed a fellowship in hematology and oncology at Cleveland Clinic. Dr. Sharfman's research interests include novel therapies for high risk and advanced melanoma patients.

Marshall, Catherine H MD, situated in Baltimore, MD, is a prominent medical facility known for its dedication to providing top-tier patient care and cutting-edge medical research. Boasting a network of hospitals, clinics, and medical centers, this establishment offers a wide range of healthcare services, from general medical attention to specialized treatments in various fields such as cardiology, neurology, oncology, and pediatrics. The medical professionals and researchers at Marshall, Catherine H MD, work in close collaboration to push the boundaries of medical innovation, aiming to enhance patient outcomes and advance healthcare practices. At Marshall, Catherine H MD, a strong emphasis is placed on education and training, ensuring that the next generation of healthcare providers and researchers are well-equipped to maintain the institution's legacy of excellence. By fostering a culture of continuous learning, scientific progress, and collaborative care, Marshall, Catherine H MD, remains at the forefront of healthcare innovation in Baltimore, MD, and beyond. With a steadfast commitment to advancing medical knowledge and improving patient well-being, Marshall, Catherine H MD, stands as a beacon of quality healthcare services and research-driven solutions. Generated using this brand's available information

Dr. Matthias Holdhoff is a medical oncologist and co-director of the Brain Cancer Disease Group at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. He is a professor of oncology, neurology and neurological surgery at Johns Hopkins University School of Medicine. Dr. Holdhoff’s expertise is in primary brain cancers and central nervous system lymphomas. He earned his medical degree from Freie Universität Berlin, received his doctorate degree at Charité University Medicine Berlin. Dr. Holdhoff completed residency training in internal medicine at Johns Hopkins Bayview Medical Center, followed by a fellowship in medical oncology at Johns Hopkins Hospital with research training at the Ludwig Center for Cancer Genetics and Therapeutics (Kinzler-Vogelstein lab). As a clinical investigator in neuro-oncology, his research is focused on novel trials and translational biomarker studies in malignant gliomas and primary central nervous system lymphomas. He has led and contributed to numerous clinical trials, publications and presentations. Dr. Holdhoff serves as the director of the solid tumor inpatient service at the Sidney Kimmel Comprehensive Cancer Center. He is passionately involved in mentoring and teaching of fellows, residents and students. He is the director of the UCNS-certified neuro-oncology fellowship program at Johns Hopkins, and he is a teaching attending physician for the Osler internal medicine residency program.